Trial
NCT02788656
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brigham and Women's Hospital
Collaborators
Novartis
Condition
Congestive Heart Failure
Intervention
Implantable Hemodynamic Monitor
Why stopped
Inadequate Recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-17